Research Center for High Altitude Medicine, Qinghai University Medical College, Xining, China.
State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining, China.
Curr Drug Metab. 2022;23(1):8-20. doi: 10.2174/1389200223666220128141038.
The characteristics of pharmacokinetics and the activity and expression of drugmetabolizing enzymes and transporters significantly change under a high-altitude hypoxic environment. Gut microbiota is an important factor affecting the metabolism of drugs through direct or indirect effects, changing the bioavailability, biological activity, or toxicity of drugs and further affecting the efficacy and safety of drugs in vivo. A high-altitude hypoxic environment significantly changes the structure and diversity of gut microbiota, which may play a key role in drug metabolism under a high-altitude hypoxic environment.
An investigation was carried out by reviewing published studies to determine the role of gut microbiota in the regulation of drug-metabolizing enzymes and transporters. Data and information on expression change in gut microbiota, drug-metabolizing enzymes, and transporters under a high-altitude hypoxic environment were explored and proposed.
High-altitude hypoxia is an important environmental factor that can adjust the structure of the gut microbiota and change the diversity of intestinal microbes. It was speculated that the gut microbiota could regulate drugmetabolizing enzymes through two potential mechanisms, the first being through direct regulation of the metabolism of drugs in vivo and the second being indirect, i.e., through the regulation of drug-metabolizing enzymes and transporters, thereby affecting the activity of drugs.
This article reviews the effects of high-altitude hypoxia on the gut microbiota and the effects of these changes on drug metabolism.
在高原缺氧环境下,药物代谢酶和转运体的药代动力学特征以及活性和表达会发生显著变化。肠道微生物群是通过直接或间接影响药物代谢,改变药物的生物利用度、生物活性或毒性,从而进一步影响药物在体内疗效和安全性的重要因素。高原缺氧环境会显著改变肠道微生物群的结构和多样性,这可能在高原缺氧环境下的药物代谢中发挥关键作用。
通过回顾已发表的研究,探讨了肠道微生物群在调节药物代谢酶和转运体中的作用。探讨并提出了高原缺氧环境下肠道微生物群、药物代谢酶和转运体表达变化的数据和信息。
高原缺氧是一种重要的环境因素,可调节肠道微生物群的结构,改变肠道微生物的多样性。据推测,肠道微生物群可能通过两种潜在机制来调节药物代谢酶,第一种是通过直接调节体内药物的代谢,第二种是通过间接调节药物代谢酶和转运体,从而影响药物的活性。
本文综述了高原缺氧对肠道微生物群的影响以及这些变化对药物代谢的影响。